You are currently viewing a new version of our website. To view the old version click .

Pleural Cavity Tumor Microenvironment: Primary and Metastatic Tumors

This special issue belongs to the section “Tumor Microenvironment“.

Special Issue Information

Dear Colleagues,

Pleural effusion is a major diagnostic and therapeutic problem with more than 1.5 million patients suffering from this condition in the United States every year. Cancer is one of the commonest etiologies of pleural effusion, and both metastatic diseases and primary tumors show poor prognosis and urge for therapeutic advance. Immunotherapy has demonstrated promising results in various forms of cancer, and its utility in pleural diseases is under investigation. Furthermore, basic, and translational studies are trying to elucidate the role of the numerous factors of the tumor microenvironment, like inflammatory cells, vascular bed, extracellular matrix, extracellular vesicles, neural fibers in various forms of cancer, including the pleural cavity, which has unique physiological characteristics.

This Special Issue aims to gather all recent development in the tumor microenvironment of the pleural cavity, in terms of basic and translational science, but also of clinical and therapeutic advance.

Dr. Georgia Karpathiou
Prof. Dr. Marios Froudarakis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mesothelioma
  • inflammation
  • pleural effusion
  • pleural metastases
  • matrix
  • exosomes
  • immunotherapy
  • vascular density
  • fibrosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694